Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -148,125 | -149,105 | -102,070 | -99,421 | -66,923 |
| Depreciation Amortization | 2,505 | -799 | -900 | 825 | 1,036 |
| Accounts receivable | 196 | -117 | 54 | 951 | -1,003 |
| Accounts payable and accrued liabilities | 3,254 | -354 | 1,819 | -2,721 | 1,139 |
| Other Working Capital | -484 | -5,114 | -7,318 | -4,204 | 29,067 |
| Other Operating Activity | 31,662 | 17,289 | 15,124 | 13,604 | 4,165 |
| Operating Cash Flow | $-110,992 | $-138,200 | $-93,291 | $-90,966 | $-32,519 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 252,830 | 397,492 | 338,188 | 252,868 | 0 |
| PPE Investments | -1,359 | -4,867 | -11,613 | -6,454 | -2,121 |
| Purchase Of Investment | -149,233 | -304,393 | -394,758 | -339,063 | -173,276 |
| Other Investing Activity | 0 | -1,625 | 0 | -600 | -1,000 |
| Investing Cash Flow | $102,238 | $86,607 | $-68,183 | $-93,249 | $-176,397 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -119 |
| Common Stock Issued | 4,076 | 15,810 | 154,298 | 2,133 | 323,571 |
| Common Stock Repurchased | 745 | 914 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 109,977 |
| Financing Cash Flow | $4,821 | $16,724 | $154,298 | $2,133 | $433,429 |
| Beginning Cash Position | 16,339 | 51,208 | 58,384 | 240,466 | 15,953 |
| End Cash Position | 12,406 | 16,339 | 51,208 | 58,384 | 240,466 |
| Net Cash Flow | $-3,933 | $-34,869 | $-7,176 | $-182,082 | $224,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,992 | -138,200 | -93,291 | -90,966 | -32,519 |
| Capital Expenditure | -1,359 | -4,880 | -11,613 | -6,454 | -2,121 |
| Free Cash Flow | -112,351 | -143,080 | -104,904 | -97,420 | -34,640 |